Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate

IntroductionIn one third of all patients with epilepsy, seizure freedom is not achieved through anti-seizure medication (ASM). These patients have an increased risk of earlier death, poorer cognitive development, and reduced quality of life. Cenobamate (CNB) has recently been approved as a promising...

Full description

Bibliographic Details
Main Authors: Konstantin L. Makridis, Thomas Bast, Christine Prager, Tatjana Kovacevic-Preradovic, Petra Bittigau, Thomas Mayer, Eva Breuer, Angela M. Kaindl
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Neurology
Subjects:
epilepsy
Cenobamate
anti-seizure medication
seizure freedom
outcome
children
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.950171/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.950171/full

Similar Items